$28.23
-0.04[-0.14%]
At close: May 10
$28.23
0[0.00%]
After Hours: 4:00PM EDT
Protagonist Therapeutics
(NASDAQ:PTGX)Overview Rating
Promising
Protagonist Therapeutics Stock (NASDAQ:PTGX), Quotes and News Summary
Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.
| Open | $28.570 |
| Close | $28.230 |
| Volume / Avg. | 513.289K / 562.145K |
| Day Range | 27.930 - 28.765 |
| 52 Wk Range | 13.720 - 33.340 |
| Market Cap | $1.656B |
| P/E Ratio | 11.146 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 61 |
| Short Interest | 6.09% |
| Days to Cover | 5.65 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Protagonist Therapeutics (PTGX) stock?
You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.
Who are Protagonist Therapeutics's (PTGX) competitors?
Other companies in Protagonist Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).
What is the target price for Protagonist Therapeutics (PTGX) stock?
The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by HC Wainwright & Co. on Thursday, May 9, 2024. The analyst firm set a price target for 38.00 expecting PTGX to rise to within 12 months (a possible 34.61% upside). 16 analyst firms have reported ratings in the last year.
Current Stock Price for Protagonist Therapeutics (PTGX)?
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $28.23 last updated May 10, 2024 at 4:00 PM EDT.
Does Protagonist Therapeutics (PTGX) pay a dividend?
There are no upcoming dividends for Protagonist Therapeutics.
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Protagonist Therapeutics (PTGX) going to split?
There is no upcoming split for Protagonist Therapeutics.
What sector and industry does Protagonist Therapeutics (PTGX) operate in?
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.